Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland

被引:23
作者
Teymoortash, A.
Schrader, C.
Shimoda, H.
Kato, S.
Werner, J. A.
机构
[1] Univ Marburg, Dept Otolaryngol Head & Neck Surg, D-35037 Marburg, Germany
[2] Univ Schleswig Holstein, Dept Internal Med & Hematol, Kiel, Germany
[3] Oita Univ, Fac Med, Dept Anat Biol & Med, Oita 87011, Japan
关键词
Warthin's tumor; pleomorphic adenoma; LYVE-1; parotid gland; lymphangiogenesis;
D O I
10.1016/j.oraloncology.2006.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The details of the pathogenesis of cystadenolymphoma (Warthin's tumor) of the parotid gland are still unclear. Neovascularization is considered to be a pivotal factor for solid tumor progression and biological behavior of the tumor. Using double-labeling immunohistochemistry for LYVE-1 and CD34 (specific markers for lymphatic and vascular endothetial cells, respectively) this study analyzes lymphatic vessel density (LVD) and blood vessel density (BVD) in 10 Warthin's tumors and 10 pleomorphic adenomas of the parotid gland as well as in 5 normal parotid glands and 5 normal parotid lymph nodes. There was no significant difference in the intratumoral LVD and BVD among pleomorphic adenoma and normal parotid gland tissue. In contrast, the intratumoral LVD and BVD were significantly higher in Warthin's tumor than pleomorphic adenoma, normal parotid gland and parotid lymph node (P < 0.0001 versus P < 0.004). The increase in lymphatic vessels in Warthin's tumor suggests that epithelial. tumor cells might promote lymphangiogenesis in this kind of lesions. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 24 条
[1]   Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody [J].
Akishima, Y ;
Ito, K ;
Zhang, L ;
Ishikawa, Y ;
Orikasa, H ;
Kiguchi, H ;
Akasaka, Y ;
Komiyama, K ;
Ishii, T .
VIRCHOWS ARCHIV, 2004, 444 (02) :153-157
[2]  
Albrecht H., 1910, FRANKFURT Z PATHOL, V4, P47
[3]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[4]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[5]  
Carreira CM, 2001, CANCER RES, V61, P8079
[6]   Lymphatic vessel density is significantly increased in melanoma [J].
Giorgadze, TA ;
Zhang, PJ ;
Pasha, T ;
Coogan, PS ;
Acs, G ;
Elder, DE ;
Xu, X .
JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (10) :672-677
[7]   Clonal analysis of the epithelial component of Warthin's tumor [J].
Honda, K ;
Kashima, K ;
Daa, T ;
Yokoyama, S ;
Nakayama, I .
HUMAN PATHOLOGY, 2000, 31 (11) :1377-1380
[8]   LYVE-1, the lymphatic system and tumor lymphangiogenesis [J].
Jackson, DG ;
Prevo, R ;
Clasper, S ;
Banerji, S .
TRENDS IN IMMUNOLOGY, 2001, 22 (06) :317-321
[9]   Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis [J].
Jackson, DG .
APMIS, 2004, 112 (7-8) :526-538
[10]  
Jackson SR, 2001, BEHAV NEUROL, V13, P1